Valuation: SK Biopharmaceuticals Co., Ltd.

Market Cap 6,07700Cr 410.39Cr 359.71Cr 333.3Cr 306.77Cr 578.47Cr 40TCr 585.47Cr 3.98TCr 1.56TCr 19TCr 1.54TCr 1.51TCr 67TCr P/E 2026 *
20.7x
P/E 2027 * 16.7x
Enterprise Value 557.61Cr 37.66L 33.01L 30.58L 28.15L 53.08L 36Cr 53.72L 3.65Cr 1.43Cr 18Cr 1.41Cr 1.38Cr 61Cr EV / Sales 2026 *
5.85x
EV / Sales 2027 * 4.7x
Free-Float
49.83%
Yield 2026 *
-
Yield 2027 * -
1 day+1.04%
1 week+4.02%
Current month-10.39%
1 month-10.80%
3 months-23.92%
6 months-31.93%
Current year-37.72%
1 week 75,800
Extreme 75800
80,500
1 month 74,000
Extreme 74000
92,400
Current year 74,000
Extreme 74000
1,27,900
1 year 74,000
Extreme 74000
1,44,100
3 years 72,600
Extreme 72600
1,44,100
5 years 50,900
Extreme 50900
1,44,100
10 years 50,900
Extreme 50900
2,69,500
Manager TitleAgeSince
Chief Executive Officer 58 01/01/2023
Director of Finance/CFO 53 -
Chief Tech/Sci/R&D Officer 46 01/04/2024
Director TitleAgeSince
Director/Board Member 54 28/03/2023
Director/Board Member 58 26/02/2020
Director/Board Member 61 26/03/2025
Date Insider Type Main position Quantity % Market Cap.
06/01/25 Others 4,500 0.0057%
20/03/24 Others

Chief Financial Officer

6,300 0.0080%
20/03/24 Don

Chief Financial Officer

6,300 0.0080%
Change 5-day change 1-year change 3-year change Capi.($)
+1.04%+4.02%-24.22%-9.13% 410.39Cr
+1.50%+4.54%+59.20%+14.38% 31TCr
+1.97%-2.71%+25.10%-13.49% 6.66TCr
+1.96%+4.73%+40.56%+83.26% 932.3Cr
-1.13%-0.47%+5.97%-3.77% 853.49Cr
+4.31%-13.35%-7.38%+21.67% 375.79Cr
+0.58%+4.35%-44.72%+9.07% 350.52Cr
+0.95%+2.59%+44.06%+56.39% 277.84Cr
+1.12%+0.39%+10.15%-7.33% 219.47Cr
+0.66%+2.66%-19.01%+32.94% 189.57Cr
Average +1.29%-1.37%+8.97%+18.40% 4.15TCr
Weighted average by Cap. +1.53%-0.41%+49.18%+11.12%

Financials

2026 *2027 *
Net sales 95TCr 64Cr 56Cr 52Cr 48Cr 91Cr 6.2TCr 92Cr 624.07Cr 244.21Cr 3.04TCr 241.69Cr 236.48Cr 10TCr 1,12100Cr 76Cr 66Cr 61Cr 57Cr 106.69Cr 7.29TCr 107.98Cr 733.66Cr 287.1Cr 3.57TCr 284.13Cr 278.01Cr 12TCr
Net income 29TCr 20Cr 17Cr 16Cr 15Cr 28Cr 1.91TCr 28Cr 192.18Cr 75Cr 935.82Cr 74Cr 73Cr 3.23TCr 36TCr 25Cr 22Cr 20Cr 18Cr 35Cr 2.37TCr 35Cr 238.5Cr 93Cr 1.16TCr 92Cr 90Cr 4.01TCr
Net Debt -50TCr -34Cr -30Cr -27Cr -25Cr -48Cr -3.26TCr -48Cr -327.96Cr -128.34Cr -1.6TCr -127.01Cr -124.28Cr -5.51TCr -81TCr -54Cr -48Cr -44Cr -41Cr -77Cr -5.24TCr -78Cr -527.79Cr -206.53Cr -2.57TCr -204.4Cr -200Cr -8.87TCr
Logo SK Biopharmaceuticals Co., Ltd.
SK Biopharmaceuticals Co Ltd is a Korea-based company mainly engages in the development and manufacture of pharmaceuticals. The Company mainly develops and produces pharmaceuticals including epilepsy drugs, sleep disorder drugs, rare neurological disorder drugs, concentration disorder drugs, schizophrenia drugs, and bipolar disorder drugs, among others. The Company also engages in the new drug development business.
Employees
246
Date Price Change Volume
21/26/21 ₩77,600.00 +1.04% 1,14,676
20/26/20 ₩76,800.00 -3.27% 97,060
16/26/16 ₩79,400.00 +1.53% 1,08,271
15/26/15 ₩78,200.00 +4.83% 1,31,997
14/26/14 ₩74,600.00 -5.93% 1,69,976
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
77,600.00KRW
Average target price
1,34,909.09KRW
Spread / Average Target
+73.85%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A326030 Stock